UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 8-A
 
FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(b) OR (g) OF THE
SECURITIES EXCHANGE ACT OF 1934
 
 
cbdMD, INC.
(Exact name of registrant has specified in its charter)
 
North Carolina
47-3414576
(State of incorporation or organization)
(I.R.S. Employer Identification No.)
 
8845 Red Oak Boulevard, Charlotte, NC
28217
(Address of principal executive offices)
(Zip Code)
 
Securities to be registered pursuant to Section 12(b) of the Act:
 
Title of each class to be so registered
Name of each exchange on which each class is to be registered
8.0% Series A Cumulative Convertible Preferred Stock
NYSE American LLC
 
If this form related to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c), check the following box ☒
 
If this form related to the registration of a class of securities pursuant to Section 12 (g) of the Exchange Act and is effective pursuant to General Instruction A.(d), check the following box ☐
 
If this form relates to the registration of a class of securities concurrently with a Regulation A offering, check the following box ☐
 
Securities Act registration statement or Regulation A offering statement file number to which this form relates: 333-228773
 
Securities to be registered pursuant to Section 12(g) of the Act: None
 

 
 
 
INFORMATION REQUIRED IN REGISTRATION STATEMENT
 
Item 1. Description of Registrant’s Securities to be Registered.
 
The description of the 8.0% Series A Cumulative Convertible Preferred Stock, par value $0.001 per share (the “Series A Convertible Preferred Stock”), of cbdMD, Inc. (the “Registrant”), as included under the heading “Description of the Series A Convertible Preferred Stock” in the Registrant’s prospectus, dated October 10, 2019, forming a part of the shelf Registration Statement on Form S-3 originally filed with the Securities and Exchange Commission (the “Commission”) pursuant to the Securities Act of 1933, as amended, on December 13, 2018 (Registration No. 333-228773), including exhibits, and as subsequently amended from time to time (the “Registration Statement”), which Registration Statement was declared effective by the Commission on April 9, 2019, is hereby incorporated by reference.
 
The Registrant has applied for listing of its Series A Convertible Preferred Stock to be registered hereunder on the NYSE American LLC under the symbol “YCBDPRA.”
 
Item 2. Exhibits.
 
    

  

Incorporated by Reference
Filed or
Furnished
No.
 
Exhibit Description
 
  Form
 
Date Filed 
 
Number 
 
 Herewith
 
Articles of Incorporation
 
1-A
 
9/18/17
 
2.1
 
 
 
Articles of Amendment to the Articles of Incorporation filed April 22, 2015
 
1-A
 
9/18/17
 
2.2
 
 
 
Articles of Amendment to the Articles of Incorporation filed June 22, 2015
 
1-A
 
9/18/17
 
2.3
 
 
 
Articles of Amendment to the Articles of Incorporation filed November 17, 2016
 
1-A
 
9/18/17
 
2.4
 
 
 
Articles of Amendment to the Articles of Incorporation filed December 5, 2016
 
1-A
 
9/18/17
 
2.5
 
 
 
Articles of Amendment to the Articles of Incorporation filed April 22, 2019
 
8-K
 
4/29/19
 
3.7
 
 
 
Articles of Amendment to the Articles of Incorporation including the Certificate of Designations, Rights and Preferences of the 8% Series A Cumulative Convertible Preferred Stock filed October 11, 2019
 
 
 
 
 
 
 
Filed
 
 
2
 
 
SIGNATURE
 
Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized.
 
 
cbdMD, INC.
 
 
 
 
 
October 11, 2019
By:  
/s/ Mark S. Elliott  
 
 
 
Mark S. Elliott, Chief Financial Officer and Chief Operating Officer
 
 
 

 
 
 
 
 
 
 
 
 
3
  Exhibit 3.1(f)